Allot Allows Telecom Providers to Leverage Their Networks for Increased Revenues; We view Allot`s Mobile Network Security operations as a growth engine for the company’s revenues in the coming years; we initiate coverage on Allot at a share price target of $12.0 Read More » Brainsway Ltd: The company’s main competitor has completed an IPO, providing for a new benchmark to Brainsway’s valuation; target price unchanged. Read More » Brainsway Ltd: The Company continues to generate consistent growth based on the rental model with sufficient cash available for 2018, without the need for further capital raising; target price unchanged. Read More » Brainsway Ltd: The Company continues to generate consistent growth based on the rental model with sufficient cash available for 2018; Mild setback in FDA marketing approval (OCD); Price target remains within the forecast range. Read More » Brainsway Ltd.: The Company continues to generate consistent growth based on the rental model; we assume operating balance in 2018; Capital raising reflects the confidence of institutional investors. Price target remains within the forecast range. Read More » Brainsway Ltd.: The company continues with its lease-based model; we expect an operational balance by 2018; Credit line granted will support rapid growth. Target price unchanged. Read More » Brainsway Ltd.: Market Trends Drive Revenue Growth. An Opportunity for Increased Value based on the scenario of the Successful Execution of the New Business Model Read More »
Allot Allows Telecom Providers to Leverage Their Networks for Increased Revenues; We view Allot`s Mobile Network Security operations as a growth engine for the company’s revenues in the coming years; we initiate coverage on Allot at a share price target of $12.0 Read More »
Brainsway Ltd: The company’s main competitor has completed an IPO, providing for a new benchmark to Brainsway’s valuation; target price unchanged. Read More »
Brainsway Ltd: The Company continues to generate consistent growth based on the rental model with sufficient cash available for 2018, without the need for further capital raising; target price unchanged. Read More »
Brainsway Ltd: The Company continues to generate consistent growth based on the rental model with sufficient cash available for 2018; Mild setback in FDA marketing approval (OCD); Price target remains within the forecast range. Read More »
Brainsway Ltd.: The Company continues to generate consistent growth based on the rental model; we assume operating balance in 2018; Capital raising reflects the confidence of institutional investors. Price target remains within the forecast range. Read More »
Brainsway Ltd.: The company continues with its lease-based model; we expect an operational balance by 2018; Credit line granted will support rapid growth. Target price unchanged. Read More »
Brainsway Ltd.: Market Trends Drive Revenue Growth. An Opportunity for Increased Value based on the scenario of the Successful Execution of the New Business Model Read More »
